Table 3.
HIV-infected n=37 |
HIV-uninfected n=29 |
|
---|---|---|
SCREENING | ||
VIA | 29(78) | 24(83) |
Pap | 25(68) | 19(66) |
HPV DNA | 13(35) | 10(34) |
VILI | 10(27) | 9(31) |
Colposcopy +/− biopsy | 4(11) | 3(10) |
TREATMENT | ||
None | 3(8) | 1(3) |
Premalignant lesions | ||
Cryotherapy | 27(73) | 21(72) |
LEEP | 21(57) | 17(59) |
Conization | 12(32) | 10(34) |
Malignant lesions | ||
Radical or extended hysterectomy | 18(49) | 16(55) |
Chemotherapy | 9(24) | 10(34) |
Radiation therapy | 5(14) | 5(17) |
Data are n(%)
Sites may report more than one screening and treatment method
Sites may be included in both HIV-infected and HIV-uninfected women columns if sites report screening and treatment programs regardless of HIV status.
Pap – Papanicolaou test, VIA -visual inspection with acetic acid, VILI - visual inspection with Lugol’s solution, HPV – human papilloma virus DNA test